Loading...
Prognostic Significance of Treatment Response in CML in View of Current Recommendations for Treatment and Monitoring
The use of small-molecule kinase inhibitors has redefined the management of cancer. Chronic myelogenous leukaemia (CML) has become the paradigm for targeted cancer treatment. Imatinib has become the gold standard in the treatment of CML with excellent and durable responses and minimal side effects....
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573397/ https://ncbi.nlm.nih.gov/pubmed/23556080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620711402415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|